Karin Hehenberger
Signal active
Founder & CEO
Bio
Karin Hehenberger is the Founder & Chief Executive Officer at Lyfebulb. She has also attended Harvard Medical School in 1998.
Location
New York, New York, United States, North America
Social
Primary Organization
LyfeBulb
Founded
2014
Investment
1
Lead investment
0
Exits
0
Employees
1-10
Industry
Health Care, Medical
Jobs history
2
3B Future Health Fund
Medical and Scientific Consultant
2011 - Current
LyfeBulb
Founder & CEO
2014 - Current
Board and Advisor Roles
3
AnaCardio
Board of Directors
2022 - Current
American Diabetes Association
Board Member NY/NJ
2019 - Current
Rolf Lufts Foundation for Diabetes Research
Board Member
2004 - Current
Invest in regions
Profile Resume
Karin Hehenberger is the Founder & CEO at LyfeBulb, based in New York, New York, United States, North America. With a background in Health Care, Karin Hehenberger has a rich history of leadership and innovation. Karin Hehenberger studied PhD Molecular biology/Diabetes @ Harvard Medical School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
1
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Sep 07, 2022 | AnaCardio | Series A - AnaCardio | - | 14.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity